Cigna Group’s (CI) Outperform Rating Reaffirmed at Royal Bank Of Canada

Cigna Group (NYSE:CI)‘s stock had its “outperform” rating restated by stock analysts at Royal Bank Of Canada in a research note issued on Thursday, Benzinga reports. They currently have a $337.00 target price on the health services provider’s stock. Royal Bank Of Canada’s price objective would suggest a potential upside of 24.39% from the stock’s current price.

A number of other brokerages have also issued reports on CI. Mizuho raised their target price on Cigna Group from $330.00 to $340.00 and gave the stock an “outperform” rating in a research note on Monday, June 8th. Sanford C. Bernstein raised their target price on Cigna Group from $371.00 to $381.00 and gave the stock an “outperform” rating in a research note on Thursday, July 9th. Jefferies Financial Group lowered Cigna Group from a “buy” rating to a “hold” rating and reduced their target price for the stock from $336.00 to $307.00 in a research note on Tuesday, August 4th. Raymond James Financial lowered Cigna Group from a “strong-buy” rating to an “outperform” rating and reduced their target price for the stock from $350.00 to $320.00 in a research note on Monday, August 3rd. Finally, Guggenheim raised their target price on Cigna Group from $338.00 to $361.00 and gave the stock a “buy” rating in a research note on Friday, July 31st. Fifteen research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $338.24.

Cigna Group Stock Up 1.1%

Shares of CI traded up $2.96 during midday trading on Thursday, hitting $270.92. 1,910,757 shares of the company’s stock traded hands, compared to its average volume of 1,686,080. Cigna Group has a 1 year low of $239.51 and a 1 year high of $315.47. The firm’s fifty day moving average is $279.18 and its 200-day moving average is $280.56. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68. The stock has a market capitalization of $71.59 billion, a price-to-earnings ratio of 11.21, a price-to-earnings-growth ratio of 0.92 and a beta of 0.29.

Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, beating the consensus estimate of $7.60 by $0.18. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The firm had revenue of $71.56 billion during the quarter, compared to analyst estimates of $70.14 billion. During the same quarter in the prior year, the business posted $7.20 EPS. The business’s revenue for the quarter was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, sell-side analysts anticipate that Cigna Group will post 30.45 earnings per share for the current year.

Insider Transactions at Cigna Group

In other Cigna Group news, insider Nicole Jones sold 19,436 shares of Cigna Group stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the completion of the transaction, the insider owned 27,256 shares in the company, valued at approximately $7,530,015.12. This trade represents a 41.63% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of Cigna Group stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total value of $175,258.85. Following the transaction, the insider owned 5,053 shares of the company’s stock, valued at $1,435,304.65. The trade was a 10.88% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 22,730 shares of company stock valued at $6,293,359 in the last quarter. Company insiders own 0.60% of the company’s stock.

Hedge Funds Weigh In On Cigna Group

A number of institutional investors have recently modified their holdings of CI. Osbon Capital Management LLC purchased a new position in shares of Cigna Group during the 2nd quarter valued at about $26,000. Cedar Mountain Advisors LLC grew its position in shares of Cigna Group by 161.9% during the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock valued at $29,000 after acquiring an additional 68 shares during the period. Johnson Financial Group Inc. acquired a new stake in shares of Cigna Group during the 2nd quarter valued at about $29,000. Fiduciary Financial Advisors acquired a new stake in shares of Cigna Group during the 2nd quarter valued at about $29,000. Finally, ANTIPODES PARTNERS Ltd acquired a new stake in shares of Cigna Group during the 2nd quarter valued at about $34,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

About Cigna Group

The Cigna Group (NYSE: CI) is a global health company that provides health care and related services to individuals, employers, government organizations and health plans. Its operations are primarily organized through Cigna Healthcare and Evernorth Health Services, which together address health coverage, pharmacy services, care delivery and benefit management.

Cigna Healthcare offers medical, dental, behavioral health, disability and other benefits, with a focus on employer-sponsored and individual health plans in the United States as well as international health services.